Hepatitis B virus (HBV) infection is common among people with HIV owing to shared modes
of viral transmission. Compared with individuals with HBV infection alone, people with …

This scoping review aims to explore the interplay between substance use (SU) and HIV in
Latin America (LA). Database searches yielded 3481 references; 196 were included. HIV …

Background: LncRNA is a key factor influencing tumor development. The present study
aimed to investigate the effect of a novel lncRNA on the progression of hepatocellular …

Chronic infections with either hepatitis B or C virus (HBV or HCV) are among the most
common risk factors for developing hepatocellular carcinoma (HCC). The …

Background The efficient use of antiretroviral drugs has significantly reduced AIDS-related
morbidities and mortalities; however, mortality due to non-AIDS-related end-stage liver …

Abstract Background Hepatitis B virus (HBV) infection continues to be a global public health
problem. As of 2019, there were 296 million people chronically infected with HBV, resulting …

In individuals infected with hepatitis B virus (HBV), the loss of hepatitis B surface antigen
(HBsAg) is the ultimate therapeutic goal, which defines “functional cure.” For individuals …

Background It is uncertain whether people with HIV infection have a higher incidence of
hepatocellular carcinoma (HCC) than the general population. Aims To compare the …

Background & Aims Tenofovir is recommended as part of the first-line antiretroviral therapy
(ART) to treat people living with HIV (PLWH) with HBV coinfection. However, the effects of …

Background: Hepatitis B surface antigen (HBsAg) clearance is vital for a functional cure of
hepatitis B virus (HBV) infection. However, the incidence and predictors of HBsAg …